Mylan Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (54)

Latest Posts

About This Stock More About This Stock
AskSlim Market Week, Nov. 8
Video By: Steve Miller
Friday, November 8, 2019 10:04 PM EST
Looking back at a week that started hot and slowly cooled for stocks, and was bad for bonds. What does next week have in store?
In this video: CPRI, HPQ, KBH, OXY, BIDU, REGN, BIIB, EXPE, MYL, QCOM, TRIP Also: QQQ, DIA, SPY
Watch
Top Five Weekend Stock Stories For September 22, 2019
Article By: The Fly
Sunday, September 22, 2019 10:55 PM EST
Catch up on the weekend's top five stories with this list compiled by The Fly/
In this article: ABC, ABT, CAH, CL, CMG, CVS, DAL, DB, JNJ, K, KMB, KO, MCD, MCK, PEP, PG, WAB, WEN, YUM, BNPQY, REAL, SFTBF, SFTBY, CMCSA, CMCSK, ENDP, MSFT, MYL, TEVA, FB, MNK, FANG, QSR, EHC, AMRX, WE
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes
Monday, September 9, 2019 7:36 PM EST
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
Pfizer, Mylan Announce Agreement To Combine Mylan With Upjohn
Article By: The Fly
Monday, July 29, 2019 9:10 AM EST
Mylan N.V. and Pfizer Inc. announced a definitive agreement to combine Mylan with Upjohn, Pfizer's off-patent branded and generic established medicines business, creating a new global pharmaceutical company.
In this article: PFE, MYL
Read
Pfizer Near Deal To Merge Off-Patent Business With Mylan
Article By: The Fly
Sunday, July 28, 2019 2:38 PM EST
Pfizer (PFE) is in talks to merge its off-patent drugs business with Mylan (MYL) and a deal could be announced as soon as Monday, Jonathan Rockoff and Cara Lombardo of Wall Street Journal report.
In this article: PFE, MYL
Read

PARTNER HEADLINES

Latest Tweets for $MYL

No tweets yet!